Orca Bio

Life Sciences

back to list

[Details]

Stage

Founded

Region

Fund

website

twitter

[overview]

Orca Bio is a clinical-stage biotechnology company developing a pipeline of high precision allogeneic cell therapy products that are designed to safely replace patients’ diseased blood and immune system with a healthy one. Their manufacturing platform sorts donor blood with single-cell precision and a high level of purity and speed, enabling us to create proprietary, optimal therapeutic mixtures of immune and stem cells that have the potential to transform allogeneic cell therapy.

[links]

A New Leukemia Cure with Ivan Dimov of Orca Bio

News

Jun 18, 2020

Announcing Our Investment in Orca Bio

Every year in America, roughly 23,000 people undergo a Bone Marrow Transplant (BMT). These procedures are typically last-line interventions to save cancer patients. When successful, the therapy is often curative.

view all resources

[featured articles]